Mode
Text Size
Log in / Sign up

Non-obese women with PCOS show no significant differences in serum vitamin D levelsVitamin D Levels Show No Difference in Non-Obese PCOS Patients

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that vitamin D levels do not differ significantly between non-obese PCOS patients and healthy controls.

This meta-analysis synthesized data from 533 non-obese patients with polycystic ovary syndrome (PCOS) and 574 healthy controls to evaluate serum vitamin D levels, specifically 25(OH)D and 1,25(OH)2D. The analysis aimed to determine if vitamin D status is directly associated with the pathophysiology of PCOS or influenced by other factors.

The primary findings indicated no significant differences in serum 25(OH)D levels between non-obese PCOS patients and healthy controls. Similarly, no significant differences were found for serum 1,25(OH)2D levels. These results suggest that vitamin D deficiency may be driven by obesity rather than the underlying pathogenesis of PCOS.

The authors noted several limitations, including significant publication bias and high heterogeneity across regions, diagnostic criteria, BMI, and assay methods. Because these findings are based on observational data, no causal relationship can be established. Clinical implications suggest that while vitamin D deficiency is prevalent in some populations, it may specifically target obese patients rather than the non-obese PCOS population.

How this fits prior evidence

This meta-analysis addresses a gap regarding the specific drivers of vitamin D deficiency in PCOS. While previous evidence found that 58% of women with PCOS have vitamin D deficiency, this study suggests that such deficiency may be driven by obesity rather than PCOS pathogenesis itself, as no significant differences were found in non-obese patients.

Researchers looked at vitamin D levels in 533 women with Polycystic Ovary Syndrome (PCOS) who were not obese. They compared these results to a group of 574 healthy individuals. The study measured two types of vitamin D in the blood: 25(OH)D and 1,25(OH)2D.

The analysis found no significant differences in vitamin D levels between the women with PCOS and the healthy control group. Because these patients were not obese, the results suggest that low vitamin D might be caused by weight factors rather than the specific biology of PCOS itself.

It is important to note that this study was a meta-analysis of observational data, meaning it shows links but does not prove cause. There were also some limitations, such as differences in how studies were conducted and potential publication bias. These findings suggest that vitamin D supplements might be more specifically helpful for patients with PCOS who are also struggling with obesity.

What this means for you:
Vitamin D levels did not differ between non-obese women with PCOS and healthy controls in this study.

Common questions

Does having PCOS mean I have low vitamin D?

This study of 533 non-obese patients found no significant difference in vitamin D levels compared to healthy controls. Because the participants were not obese, the results suggest that vitamin D levels may be linked to weight rather than the specific condition of PCOS.

Is vitamin D supplementation helpful for PCOS?

The study suggests that because vitamin D levels did not differ in non-obese patients, deficiency might be driven by obesity. This implies that supplements may specifically benefit those with both PCOS and a higher BMI. Talk to your doctor about your specific needs.

What were the limitations of this research?

The study noted significant publication bias and differences in how data was collected, including variations in region, diagnostic criteria, and testing methods. These factors mean the results should be viewed as an association rather than a definitive cause.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedJun 2026
View Original Abstract ↓
IntroductionVitamin D deficiency is linked to increased risk of polycystic ovary syndrome (PCOS) and may worsen metabolic disorders such as insulin resistance. However, evidence remains inconsistent regarding vitamin D status in non−obese women with PCOS. This study aimed to perform the first systematic review and meta−analysis evaluating serum vitamin D levels in non−obese PCOS patients.MethodsRelevant studies were searched in PubMed, Embase, Cochrane Library, and Web of Science up to May 2025. Eligible studies comparing non−obese PCOS women and healthy controls were included. Two reviewers independently screened articles. Meta−analysis was conducted using a random−effects model, supplemented by subgroup, sensitivity, and publication bias analyses.ResultsEleven studies involving 533 non−obese PCOS patients and 574 controls were included. No significant differences were found in serum 25(OH)D or 1,25(OH)2D levels between groups. Heterogeneity was mainly attributed to region, diagnostic criteria, BMI, and assay methods. Significant publication bias was detected.DiscussionSerum vitamin D levels are not significantly associated with non−obese PCOS, implying vitamin D deficiency may be driven by obesity rather than PCOS pathogenesis. Vitamin D supplementation may benefit obese PCOS patients, and further prospective studies are needed.Systematic review registrationhttp://www.crd.york.ac.uk/PROSPERO, identifier CRD420251168257.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.